Logo
Global Organ Transplant Diagnostics Market 2021-2031

Global Organ Transplant Diagnostics Market 2021-2031

Bonafide Trust 30-07-2022 185 Pages
Region : Global Category : Lifescience Medical Devices

Global organ transplant diagnostics market will reach $6,072.1 million by 2031, growing by 8.8% annually over 2021-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics. Highlighted with 91 tables and 94 figures, this 185-page report “Global Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Region. Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Test Kits & Consumables o Kits & Assays o Consumables • Software & Services Based on Transplant, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solid Organ Transplant o Kidney o Liver o Heart o Lung o Pancreas o Kidney-Pancreas o Other Solid Organ Transplants • Stem Cell Transplant • Soft Tissue Transplant By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostics o Donor Testing o Recipient Testing • Translational Research By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Molecular Technologies o PCR o Sequencing o Other Molecular Technologies • Serology • Flow Cytometry • Other Technologies By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Transplant Centers • Reference Laboratories • Academic and Research Institutions • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE?Saudi Arabia? South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market Offering, Transplant and Technology over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Inc. ARUP Laboratories BAG Health Care GmbH Becton Dickinson and Company bioMérieux S.A. Bio-Rad Laboratories, Inc. CareDx, Inc. Eurofins Scientific F. Hoffmann-La Roche Ltd. Illumina, Inc. Immucor, Inc. Laboratory Corporation of America Holdings Novacyt Group Omixon Ltd. OPKO Health QIAGEN N.V. Quest Diagnostics Incorporated Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services